title: Low-dose DDAVP in nocturnal enuresis.
abstract: A five-year experience with the vasopressin analogue desmopressin acetate (DDAVP) for nocturnal enuresis is described in 59 children. The initial starting dose of 5 micrograms at bedtime is lower than that reported in other series. Eighty-one percent of patients required 10 micrograms or less to achieve improvement or resolution of bedwetting.
authors.affiliation: Department of Surgery, University of Michigan Medical Center, Ann Arbor.
authors.forename: D W
authors.initials: DW
authors.lastname: Key
authors.forename: D A
authors.initials: DA
authors.lastname: Bloom
authors.forename: J
authors.initials: J
authors.lastname: Sanvordenker
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage* / Q000627:therapeutic use; D004775:Enuresis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D016896:Treatment Outcome
chemical_list: D003894:Deamino Arginine Vasopressin